CSIMarket
 


Aldeyra Therapeutics Inc   (ALDX)
Other Ticker:  
 

Aldeyra Therapeutics Inc 's Quick Ratio

ALDX's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




Within Major Pharmaceutical Preparations industry Aldeyra Therapeutics Inc booked the highest Quick Ratio than Aldeyra Therapeutics Inc in the third quarter 2023. While total ranking remained the same in the III Quarter 2023 compared to the second quarter 2023 at no. .

Explain Quick Ratio?
How much Cash & cash equivalents ALDX´s has?
What are ALDX´s Current Liabilities?


ALDX Quick Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities Change -10.24 % -3.28 % -3.28 % 28.36 % 101.06 %
Y / Y Cash & cash equivalent Change - - - - -
Quick Ratio MRQ - - - 1.98 2.36
ALDX's Total Ranking # # # # #
Seq. Current Liabilities Change 39.26 % -2.16 % 4.67 % -37.06 % 50.06 %
Seq. Cash & cash equivalent Change - - - -47.28 % -25.1 %



Quick Ratio third quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #


Quick Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Aldeyra Therapeutics Inc 's Current Liabilities $ 22 Millions Visit ALDX's Balance sheet
Aldeyra Therapeutics Inc 's Cash & cash equivalent $ 0 Millions Visit ALDX's Balance sheet
Source of ALDX's Sales Visit ALDX's Sales by Geography


Cumulative Aldeyra Therapeutics Inc 's Quick Ratio

ALDX's Quick Ratio for the trailling 12 Months

ALDX Quick Ratio

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities TTM Growth -10.24 % -3.28 % -3.28 % 28.36 % 101.06 %
Y / Y Cash & cash equivalent TTM Growth - - - - -
Quick Ratio TTM 0.44 1.23 2.29 3.08 2.79
Total Ranking TTM
Seq. Current Liabilities TTM Growth 39.26 % -2.16 % 4.67 % -37.06 % 50.06 %
Seq. Cash & cash equivalent TTM Growth - - - -47.28 % -25.1 %


On the trailing twelve months basis In spite of the year on year decrease in ALDX's Current Liabilities to $21.55 millions, cumulative Quick Ratio to 0.44 below the ALDX average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 494 other companies have achieved higher Quick Ratio than Aldeyra Therapeutics Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2023 from 3779 to 3830.

Explain Quick Ratio?
How much Cash & cash equivalents ALDX´s has?
What are ALDX´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 495
Healthcare Sector # 1025
Within the Market #


trailing twelve months Quick Ratio Statistics
High Average Low
14.37 4.39 0.16
(Dec 31 2017)   (Mar 31 2021)




Companies with similar Quick Ratio in the quarter ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Quick RatioSep 30 2023 MRQ Cash & cash equivalentSep 30 2023 MRQ Current Liabilities

Date modified: 2023-11-04T19:52:30+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com